
Sign up to save your podcasts
Or
Plus: More Americans filed for initial jobless benefits last week. The FDA says Eli Lilly has resolved the shortage of its Tirzepatide diabetes and weight-loss drug. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.2
623623 ratings
Plus: More Americans filed for initial jobless benefits last week. The FDA says Eli Lilly has resolved the shortage of its Tirzepatide diabetes and weight-loss drug. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,632 Listeners
4,313 Listeners
1,751 Listeners
402 Listeners
443 Listeners
2,792 Listeners
1,442 Listeners
1,005 Listeners
1,280 Listeners
5,907 Listeners
1,522 Listeners
189 Listeners
1,317 Listeners
570 Listeners
151 Listeners
49 Listeners
74 Listeners
124 Listeners